T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $935B
1-Year Est. Return 30.3%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Est. Return
1 Year Est. Return
+30.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$883B
AUM Growth
+$71.2B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,193
New
Increased
Reduced
Closed

Top Buys

1 +$4.95B
2 +$3.48B
3 +$2.66B
4
AMD icon
Advanced Micro Devices
AMD
+$1.92B
5
GE icon
GE Aerospace
GE
+$1.49B

Top Sells

1 +$3.79B
2 +$2.63B
3 +$2.46B
4
FISV
Fiserv Inc
FISV
+$2.19B
5
LLY icon
Eli Lilly
LLY
+$1.78B

Sector Composition

1 Technology 34.76%
2 Financials 12.08%
3 Healthcare 10.97%
4 Consumer Discretionary 10.95%
5 Communication Services 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BARK icon
2976
BARK
BARK
$117M
$54K ﹤0.01%
62,028
DMAC icon
2977
DiaMedica Therapeutics
DMAC
$446M
$53K ﹤0.01%
+13,368
FATE icon
2978
Fate Therapeutics
FATE
$127M
$53K ﹤0.01%
46,855
+8,806
LDI icon
2979
loanDepot
LDI
$617M
$53K ﹤0.01%
+41,283
PLX icon
2980
Protalix BioTherapeutics
PLX
$141M
$53K ﹤0.01%
+35,278
GORO icon
2981
Gold Resource Corp
GORO
$125M
$52K ﹤0.01%
84,700
LFT
2982
Lument Finance Trust
LFT
$78.5M
$52K ﹤0.01%
+23,084
MYPS icon
2983
PLAYSTUDIOS Inc
MYPS
$81.8M
$52K ﹤0.01%
39,525
ZVIA icon
2984
Zevia
ZVIA
$178M
$52K ﹤0.01%
+15,945
AMTX icon
2985
Aemetis
AMTX
$107M
$51K ﹤0.01%
20,463
-17,553
RFL icon
2986
Rafael Holdings
RFL
$63.2M
$51K ﹤0.01%
29,321
-410
AIRJ
2987
Montana Technologies Corp
AIRJ
$178M
$51K ﹤0.01%
+10,871
TARA icon
2988
Protara Therapeutics
TARA
$264M
$50K ﹤0.01%
+16,353
ZNTL icon
2989
Zentalis Pharmaceuticals
ZNTL
$102M
$49K ﹤0.01%
41,454
-28,231
ILLR
2990
Triller Group Inc
ILLR
$85.1M
$49K ﹤0.01%
+52,493
TEAD
2991
Teads Holding Co
TEAD
$58.5M
$49K ﹤0.01%
19,620
+3,087
TOON icon
2992
Kartoon Studios
TOON
$40.2M
$49K ﹤0.01%
65,355
-885
KPTI icon
2993
Karyopharm Therapeutics
KPTI
$100M
$47K ﹤0.01%
+10,886
RXT icon
2994
Rackspace Technology
RXT
$251M
$47K ﹤0.01%
36,459
+8,521
HLLY icon
2995
Holley
HLLY
$519M
$45K ﹤0.01%
22,221
+1,974
CHRS icon
2996
Coherus Oncology
CHRS
$149M
$43K ﹤0.01%
58,482
+10,329
LXEO icon
2997
Lexeo Therapeutics
LXEO
$661M
$42K ﹤0.01%
10,425
NKTX icon
2998
Nkarta
NKTX
$131M
$42K ﹤0.01%
25,196
+1,238
TNYA icon
2999
Tenaya Therapeutics
TNYA
$235M
$42K ﹤0.01%
67,582
-21,988
INNV icon
3000
InnovAge Holding
INNV
$700M
$41K ﹤0.01%
+10,922